Hypothesis: A neural joint model that simultaneously learns longitudinal trajectories of multi-omic biomarkers (e.g., DNA methylation clocks, proteomic senescence markers) and time-to-event outcomes, augmented with adversarial domain adaptation to mitigate cohort shift, will outperform standard time-dependent Cox models and existing neural survival extensions in predicting cause-specific mortality in aging populations.

Rationale: Longitudinal aging studies are hampered by measurement error in repeatedly measured biomarkers and informative censoring due to dropout or competing events. Joint models address these issues by linking a mixed-effects submodel for the biomarker trajectories to a survival submodel via shared random effects, thereby correcting for bias. Current neural Cox extensions (DeepOmicsSurv, Cox-nnet) excel at capturing non-linear hazard functions but ignore the longitudinal measurement process and assume covariates are error-free. Moreover, aging datasets often originate from multiple cohorts with differing assay platforms and population characteristics, violating the assumption of identical distribution across training and test sets. Adversarial domain alignment has shown promise in genomics for learning invariant representations; applying it to the shared latent space of a joint model could reduce cohort-specific bias without sacrificing predictive power.

Predictions: 1) The proposed neural joint model will achieve a statistically significant increase in concordance index (C-index) for all-cause mortality and cause-specific mortality (cardiovascular, cancer, neurodegenerative) relative to DeepOmicsSurv and Cox-nnet when tested on independent longitudinal aging cohorts (e.g., Framingham Heart Study, Lothian Birth Cohorts, UK Biobank subset). 2) Calibration plots will show improved agreement between predicted and observed cumulative incidence functions, particularly in the presence of informative censoring. 3) Adversarial training will reduce the distribution discrepancy (measured by maximum mean discrepancy) between source and target cohort representations in the shared latent space, correlating with improved out-of-sample performance. 4) SHAP values derived from the model will highlight biologically plausible interactions (e.g., acceleration of epigenetic age amplifying the hazard of cardiovascular death when inflammation markers are high), providing testable mechanistic hypotheses.

Experimental Design: Develop a modular architecture comprising (a) a recurrent or temporal convolutional network to model longitudinal biomarker trajectories, (b) a survival submodel parameterized by a feed‑forward network outputting cause-specific hazards via competing risks softmax, (c) a shared latent vector linking the two submodels, and (d) a domain discriminator trained adversarially to make the latent vector indistinguishable across cohorts. Train on a multi‑cohort dataset with baseline and follow‑up omics, clinical covariates, and cause-of-death labels. Use stratified cross‑validation preserving cohort structure. Compare against baselines: standard joint model with linear mixed effects, DeepSurv with time‑dependent covariates, and Cox-nnet with baseline omics only. Evaluate using time‑dependent C-index, integrated Brier score, and calibration metrics. Perform ablation studies removing the adversarial component or the joint linkage to assess their individual contributions.

Potential Pitfalls: If the adversarial loss overly suppresses cohort‑specific biological signal, predictive performance may deteriorate; tuning the trade‑off hyperparameter via validation is essential. Informative censoring may remain problematic if dropout is not fully captured by the longitudinal submodel; sensitivity analyses using pattern‑mixture models will be needed. Finally, the model’s complexity demands substantial computational resources; efficient implementation (e.g., mixed‑precision training) will be required for scalability.

Falsifiability: Should the neural joint model fail to demonstrate a statistically significant improvement in C-index or calibration over the best baseline across multiple aging cohorts, the hypothesis would be refuted, indicating that either the joint modeling framework or adversarial adaptation does not adequately address the core challenges of measurement error, informative censoring, or cohort heterogeneity in longitudinal aging survival analysis.